News

After over 25 years of lending to the health and social care sector, former Virgin Money Head of Health and Social Care Jamie Stuart has taken a bold new direction—co-founding specialist dementia care provider Fortava. Candesic sits down with Jamie to explore what motivated this career shift ...

Read more

Multinational hospitals chain Medicover has expanded its collaboration with Poland-based digital agency Performance Group to include TikTok campaigns aimed at engaging younger audiences. The partnership is focused on content marketing and growing the Medistore marketplace presence on the ...

Read more

Novo Nordisk appointed Maziar Mike Doustdar as its new CEO and president on August 7, 2025, signalling a strategic shift to address challenges in the U.S. weight-loss drug market and competition from Eli Lilly. Doustdar emphasised refocusing on obesity and diabetes

Read more

Global biopharmaceutical company AstraZeneca has announced a $50 billion investment in the United States by 2030 to expand its pharmaceutical manufacturing and R&D footprint. The initiative includes a proposed multi-billion-dollar manufacturing facility in Virginia.

Read more

Multinational pharmaceutical company Merck is acquiring respiratory disease specialist Verona Pharma at a total transaction value of $10 billion (net $9.8 billion after cash and debt). The deal is driven by Ohtuvayre, Verona’s COPD treatment.

Read more

Citing "clear successes", the supervisory board of German multinational pharmaceutical and biotechnology company Bayer AG has unanimously extended CEO Bill Anderson’s contract until March 31, 2029, three years beyond its original 2026 expiration.  

Read more

Ontario Teachers Pension Plan (OTPP) has acquired 100% of Spain-based dental provider Donte Group from Advent International for approximately €1 billion, with closing expected in Q4 2025 . The deal represents one of Europe's largest dental services platform exits in recent years. 

Read more

Multinational pharmaceutical and healthcare company Sanofi completed its acquisition of Blueprint Medicines Corporation on July 18, 2025, with Blueprint becoming an indirect, fully owned Sanofi subsidiary. The deal strengthens Sanofi’s rare disease and immunology portfolio.

Read more

Global investment group EQT  signed a definitive agreement to acquire a majority stake in global B2B pharmaceutical company Adalvo through its EQT X fund on Friday, July 18, with closing expected in H2 2025 , entering the B2B pharmaceutical dossier development sector.

Read more

GHO Capital signed an agreement to acquire a majority holding in FotoFinder Systems from EMZ Partners on Tuesday, July 8, with EMZ Partners and management reinvesting in a market facing a critical shortage of dermatologists worldwide. 

Read more